EU wholesalers concerned about packaging

The European Commission recently released its "pharmaceutical package," which has some anti-counterfeiting proposals that the European Association of Pharmaceutical Full-line Wholesalers (GIRP) finds troubling. While GIRP was pleased with new legislation to prevent some medications from entering into the legal supply chain, it raised concerns about the number of licenses that distributors across the European Union received. Report.

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.